Elucidated molecular mechanism behind safety and efficacy of BersiporocinBersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary FibrosisSEOUL, South Korea, May 25, 2023
To enhance its capabilities in the field of GI endotherapy and provide more comprehensive solutions to patients, Olympus Corporation has reached an agreement to acquire Taewoong Medical Co, Ltd, a Korean company that produces medical devices, including metallic stents for gastrointestinal (GI) use. Click to read more.
Strengthening Gastrointestinal Endotherapy Offerings Through Bringing Together Talent and TechnologyTOKYO and SEOUL, Feb 24, 2023 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company
- Hitting a record high sale with business profits of KRW 106 billion and net profits of KRW 80.1 billion according to the accounting of 2022 - Not only stable positioning of Fexuclue but
BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous